Compare Honeywell International Inc (HON) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honeywell International Inc vs Oscar Health Inc — how do they compare? Honeywell International Inc trades at $207.73 (market cap $65.48B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Honeywell International Inc is far larger — about 6.4× Oscar Health Inc's market cap, and Honeywell International Inc pays a 1.36% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Honeywell International Inc for 91 Days and Oscar Health Inc for 15 Days on average.
| HON | OSCR | |
|---|---|---|
Market Cap | $65.48B | $10.22B |
Volume | 2,047,782 | 4,123,394 |
Sector | Industrials | Health |
52-Week High | $248.79 | $33.81 |
52-Week Low | $188.14 | $10.85 |
Typical Hold Time | 91 Days | 15 Days |
Enterprise Value | $90.27B | $6.57B |
Dividend Yield | 1.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Honeywell International (HON) trades at $206.6, down 0.73% with bearish technical signals despite strong fundamental metrics including a low P/E of 7.94 and robust ROE of 47.43%. The company recently beat Q2 2026 EPS estimates and secured a $300 million refinery project, positioning for growth post-spinoff of its aerospace and advanced materials divisions. Analyst consensus remains strongly bullish with a $259.25 price target.
HON presents a compelling value opportunity with attractive valuation multiples and consistent earnings outperformance, though near-term technical weakness and increasing debt-to-asset ratios warrant caution. The company's strategic focus on automation and recent contract wins support long-term growth prospects despite cyclical industrial sector risks.
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
